|
| Status |
Public on Sep 05, 2014 |
| Title |
Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients |
| Organism |
Homo sapiens |
| Experiment type |
Methylation profiling by array
|
| Summary |
Recent studies suggest that genetic and environmental factors do not account for all the schizophrenia risk and epigenetics also plays a role in disease susceptibility. DNA methylation is a heritable epigenetic modification that can regulate gene expression. Genome-Wide DNA methylation analysis was performed on post-mortem human brain tissue from 24 patients with schizophrenia and 24 unaffected controls. DNA methylation was assessed at over 485 000 CpG sites using the Illumina Infinium Human Methylation450 Bead Chip. After adjusting for age and post-mortem interval (PMI), 4 641 probes corresponding to 2 929 unique genes were found to be differentially methylated. Of those genes, 1 291 were located in a CpG island and 817 were in a promoter region. These include NOS1, AKT1, DTNBP1, DNMT1, PPP3CC and SOX10 which have previously been associated with schizophrenia. More than 100 of these genes overlap with a previous DNA methylation study of peripheral blood from schizophrenia patients in which 27 000 CpG sites were analysed. Unsupervised clustering analysis of the top 3 000 most variable probes revealed two distinct groups with significantly more people with schizophrenia in cluster one compared to controls (p = 1.74x10-4). The first cluster was composed of 88% of patients with schizophrenia and only 12% controls while the second cluster was composed of 27% of patients with schizophrenia and 73% controls. These results strongly suggest that differential DNA methylation is important in schizophrenia etiology and add support for the use of DNA methylation profiles as a future prognostic indicator of schizophrenia
|
| |
|
| Overall design |
Genome-Wide DNA methylation analysis was performed on post-mortem human brain tissue from 24 patients with schizophrenia and 24 unaffected controls. DNA methylation was assessed at over 485 000 CpG sites using the Illumina Infinium Human Methylation450 Bead Chip.
|
| |
|
| Contributor(s) |
Wockner LF, Noble EP, Lawford BR, Young RM, Morris CP, Whitehall VL, Voisey J |
| Citation(s) |
24399042 |
| Submission date |
Sep 04, 2014 |
| Last update date |
Mar 22, 2019 |
| Contact name |
Joanne Voisey |
| E-mail(s) |
j.voisey@qut.edu.au
|
| Organization name |
Queensland University of Technology
|
| Department |
IHBI
|
| Street address |
60 Musk Ave
|
| City |
Kelvin Grove |
| State/province |
Queensland |
| ZIP/Postal code |
4059 |
| Country |
Australia |
| |
|
| Platforms (1) |
| GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
|
| Samples (48)
|
|
| Relations |
| BioProject |
PRJNA260256 |
Less...
More...